World’s First MRIdian Center Treats 1,000th Patient with MRI-Guided Radiation Therapy
Extensive Clinical Experience at Siteman Cancer Center Helps Further Adoption and Clinical Practice of MR-guided and On-Table Adaptive Radiation Therapy
Leveraging on-table MR soft tissue imaging, MRIdian allows oncologists to visualize, adapt and target using diagnostic-quality anatomical detail that’s simply unavailable with conventional IGRT technologies.
Combining the latest innovations in precision radiation delivery, ground-breaking MR image guidance, and on-table adaptive therapy, MRIdian represents a new paradigm in radiation oncology.
World’s First MRIdian Center Treats 1,000th Patient with MRI-Guided Radiation Therapy
Extensive Clinical Experience at Siteman Cancer Center Helps Further Adoption and Clinical Practice of MR-guided and On-Table Adaptive Radiation Therapy
ViewRay® to Present at the Jefferies 2019 Global Healthcare Conference
ViewRay, Inc. (NASDAQ: VRAY) today announced that the Company will participate in the Jefferies 2019 Global Healthcare Conference in New York, NY on Thursday, June 6, 2019.
ViewRay Reports First Quarter 2019 Results
ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the first quarter ended March 31, 2019.
A new kind of medical technology company—ViewRay® Inc. designs, manufactures and markets MRIdian, the world’s first MRI-Guided radiation therapy system to image and treat cancer patients simultaneously.
Contact Us Today To Learn More Contact
This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of our products and services, assist with our promotional and marketing efforts, and provide content from third parties. Cookie Policy